China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real-World Study on the Efficacy and Safety of Inetetamab Combined with Chemotherapy for HER2-Positive Advanced Breast Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129680
Registration Time: 2026/08/07
Type: Observational study
Primary Sponsor: Tianjin Medical University Cancer Institute and Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=281677
Published by HT Digital Content Services with permission from Health Daily Digest....